Swiss Pharma Pvt Ltd, a active private limited company, was established on 23 January 1987 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1987PTC009343. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.15 Cr and a paid-up capital of ₹1.11 Cr.
It upholds a compliant status. Employing 50 professional, Its leadership includes Sharadchandra Rasiklal Shah (Managing Director), Darshan Sharadchandra Shah (Managing Director). Past directors included Sharadchandra Rasiklal Shah, Darshan Sharadchandra Shah, Minooben Sharadchandra Shah. It holds ₹28.10 Cr open charges and ₹6.79 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 3709 Gidc Estatephase Iv Vatva, Ahmedabad, Gujarat, 382445.
U24231GJ1987PTC009343
009343
23 January 1987
₹1.15 Cr
₹1.11 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Swiss Pharma Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sharadchandra Rasiklal Shah | Managing Director | 23 Jan 1987 | Current |
| Darshan Sharadchandra Shah | Managing Director | 01 Sep 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Nov 2011 | Past |
| Pramod Abcsdd | Ceo(Kmp) | 01 Sep 2019 | Past |
| Pramod Abcsdd | Whole-Time Director | 28 May 2020 | Past |
| Pramod Abcsdd | Director | 08 Sep 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Swiss Pharma Pvt Ltd, for the financial year ended 2024, experienced significant reduction in revenue, with a 12.55% decrease. The company also saw a substantial fall in profitability, with a 57.53% decrease in profit. The company's net worth moved up by a moderate rise of 2.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Swiss Pharma had a public holding of 1.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹280,999,000.00
₹67,945,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Sep 2024 | Others | ₹1.70 Cr | Open |
| 05 Apr 2021 | Bank Of India | ₹6.10 M | Open |
| 07 May 1994 | Bank Of India | ₹12.89 Cr | Open |
| 25 Aug 1992 | Bank Of India | ₹12.90 Cr | Open |
| 07 Jul 2018 | Bank Of India | ₹7.00 M | Satisfied |
Explore comprehensive loan charge details -
Swiss Pharma has a workforce of 50 employees as of Feb 10, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Swiss Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swiss Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Swiss Pharma Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Swiss Pharma Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
Progress on A charge with Others amounted to Rs. 1.70 Cr with Charge ID 100982676 was registered on 13 Sep 2024. was documented.
A charge registered on 28 Mar 2018 via Charge ID 100168436 with Others was fully satisfied on 26 Jun 2023. was recorded as a recent event.
Progress on A charge with Bank Of India of Rs. 12.90 Cr registered on 25 Aug 1992 with Charge ID 90385391 was modified on 05 May 2022. was documented.
The activity A charge registered on 07 Oct 2017 via Charge ID 100130474 with Others was fully satisfied on 29 Dec 2021. was completed.
Aloxi is used to prevent nausea and vomiting in patients receiving chemotherapy..
The CIN of Swiss Pharma Pvt Ltd is U24231GJ1987PTC009343.
Swiss Pharma Pvt Ltd is headquartered at 3709 Gidc Estatephase Iv Vatva, Ahmedabad, Gujarat, 382445.
Swiss Pharma Pvt Ltd was incorporated on 23 January 1987.
The current directors of Swiss Pharma Pvt Ltd are
The primary industry of Swiss Pharma Pvt Ltd is Manufacturing.
Swiss Pharma Pvt Ltd is unlisted.
The authorized capital of Swiss Pharma Pvt Ltd is ₹1.15 Cr, and the paid-up capital is ₹1.11 Cr.
The compliance status of Swiss Pharma Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX